MENU
+Compare
ORYZF
Stock ticker: OTC
AS OF
Jun 9 closing price
Price
$3.22
Change
+$0.19 (+6.27%)
Capitalization
243.16M

ORYZF Oryzon Genomics SA Forecast, Technical & Fundamental Analysis

Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics... Show more

ORYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ORYZF with price predictions
Jun 27, 2025

ORYZF's Stochastic Oscillator is remaining in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

ORYZF moved above its 50-day moving average on June 09, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for ORYZF crossed bullishly above the 50-day moving average on June 10, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 13 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for ORYZF turned negative on June 27, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 14 similar instances when the indicator turned negative. In of the 14 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for ORYZF entered a downward trend on June 06, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.706) is normal, around the industry mean (16.366). P/E Ratio (0.000) is within average values for comparable stocks, (58.189). ORYZF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.247).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORYZF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORYZF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ORYZF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Sant Ferran 74
Phone
+34 935151313
Employees
40
Web
http://www.oryzon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLTAX15.910.14
+0.89%
Catalyst/Lyons Tactical Allocation A
FHEAX16.480.07
+0.43%
Fidelity Advisor Real Estate A
VSTCX39.300.15
+0.38%
Vanguard Strategic Small-Cap Equity Inv
JCVWX24.950.08
+0.32%
JHancock Classic Value R6
ACMVX15.770.02
+0.13%
American Century Mid Cap Value Inv

ORYZF and Stocks

Correlation & Price change

A.I.dvisor tells us that ORYZF and REPL have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORYZF and REPL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORYZF
1D Price
Change %
ORYZF100%
N/A
REPL - ORYZF
30%
Poorly correlated
N/A
TVGN - ORYZF
24%
Poorly correlated
+5.08%
GNNSF - ORYZF
24%
Poorly correlated
N/A
IBIO - ORYZF
23%
Poorly correlated
N/A
BMRN - ORYZF
23%
Poorly correlated
+1.98%
More